Togafitiga o Ponokalafi Mataga Faʻaaogaina i le Naltrexone: O le Lipoti Faʻaletupe (2015)

faamatalaga: O le isi suʻesuʻega faʻataʻitaʻiga lea e faʻaalia ai o le vailaʻau Naltrexone e fesoasoani i vaisu porn e pulea a latou faʻaoga porn (o se mea mulimuli). Mo se maeʻaeʻa, ma malamalama, talanoaga o Naltrexone ma vaisu porn vaʻai i lenei mea su'esu'ega muamua.


So'oga ile Research Gate PDF ole pepa atoa

Amerika Journal of Psychiatry . 01/2016; I le Tusitala. DOI: 10.1176/appi.ajp.2015.15060843

Shane W. Kraus, PhD a, b * Sarah Meshberg-Cohen, PhD a, b Steve Martino, PhD a, b Lantie J. Quinones, MD c Marc N. Potenza, MD, PhD b

a VISN 1 A'oa'oga Su'esu'ega mo Ma'i Mafaufau ma Nofoaga Autu, VA Connecticut Healthcare System, West Haven, CT ISA

b Aoga Faafomai a le Iunivesite o Yale, New Haven, CT ISA

c McLean Hospital, Harvard Medical School, Department of Psychiatry, Belmont, MA USA

* Tusitala tutusa: Shane W. Kraus, Ph.D., VISN 1 MIRECC, VA Connecticut Healthcare System, 950 Campbell Avenue 151D, West Haven, Connecticut 06515, United States. Telefoni: 203-932-5711, Ext: 7907; imeli: [imeli puipuia]

I LE FA'ATONU:

I le va o le 30-50% o tamaloloa Amerika e matamata i ponokalafi i taimi uma, ma na o sina vaega itiiti o tagata matamata e faʻaaogaina faʻamalosi. O le faʻaaogaina o ponokalafi faʻamalosi e faʻaalia i le tuʻinanau, faʻalavelave amio, faʻaletonu agafesootai / galuega, ma maualuga maualuga o faʻamaʻi pipisi o le mafaufau (1). E tusa ai ma mataupu e lua talu ai nei na lolomiina (2, 3) o loʻo fautua mai ai le naltrexone, o le opioid-receptor antagonist, e mafai ona faʻaitiitia ai le malosi o tuʻinanauga tau feusuaʻiga ma amioga e fesoʻotaʻi ma amioga faʻafeusuaiga faʻamalosi e le paraphilic, matou te lipotia se mataupu o le naltrexone o se faʻaopoopoga i le psychotherapy i totonu. o se tane ua faaipoipo, faigaluega, taulelea i le 30 o ona tausaga o le na sailia togafitiga mo le matamataina o ponokalafi i luga o le initaneti. O le aoga o Naltrexone i le faʻaitiitia o tuʻinanauga faʻafeusuaiga e faʻamalosi i ponokalafi e tele lava ina le suʻesuʻeina.

Sa amata ona faaaoga soo e Mr. D. ponokalafi i le 13 o ona tausaga. I le taimi o le faatalanoaga o le taumafaina, sa ia lipotia ai le toto malosi i ponokalafi mo le 10 tausaga talu ai e ui i le tele o taumafaiga le manuia e tuu; sa ia matamata i ponokalafi i luga o le Initoneti toetoe lava o aso uma mo le tusa ma le 30 minute. Na ia lipotia se suʻesuʻega muamua o le maʻi tigaina tele, ma e leai sana talaʻaga o le faʻaaogaina o vailaʻau, amioga faʻafeusuaiga lamatia, faʻafitauli ogaoga faʻafomaʻi, e leʻi inu foʻi ni vailaʻau faʻatonuina.

Na amata ona auai Mr. D i vaiaso ta'itasi togafitiga fa'ale-mafaufau-amio fa'ata'ita'iina e se foma'i fa'afoma'i tulaga fa'afoma'i. Mo le 18 vaiaso, na ia faʻamaeʻaina ai le mataʻituina o le tagata lava ia i aso taʻitasi e iloilo ai faʻamalosi e matamata i ponokalafi i luga o le Initaneti (1.0 = Leai se Urge, 7.0 = Intense Urge) ma pe na ia matamata ma faʻamalosi i ponokalafi. E ui i le faʻaitiitia o lona faʻaaogaina o ponokalafi e tusa ma le 70%, na faʻaauau pea ona lipotia e Mr. D faʻasalalauga faʻafeusuaiga e faʻamalosi i ponokalafi i luga ole Initaneti.graphy. O le mea lea, i le vaiaso lona sefulu o togafitiga, na faʻatonuina ai le naltrexone (50 mg / d).

I totonu o le lua vaiaso o le amataina o fualaau, na ia lipotia ai le faʻaitiitia o le faʻaitiitia o ana faʻamalosi e faʻamalosi i ponokalafi. E pei ona faʻaalia i le Ata 1, i luga o le iva vaiaso na ia faʻaaogaina ai le naltrexone, o le malosi o ana tuʻinanauga faʻafeusuaiga na matua faʻaitiitia (M1-9 vaiaso=3.71, SD=1.28 vs. M10-18 vaiaso=2.37, SD=.80), t(124) = 6.93, p<.0001, Cohen's d=1.25). Sa ia tau le matamata foi i ponokalafi (5 aso i vaiaso 10-18; 17 aso i vaiaso 1-9), χ2 (1, N= 125) = 7.04, p<.01 (PO =.25, 95% CI = 0.09-0.73). E lē gata i lea, na ia toe faaauauina feusuaʻiga masani ma le faamalieina ma lana avā.

O a matou suʻesuʻega o loʻo fautua mai ai o le naltrexone e mafai ona avea ma se togafitiga faʻapipiʻi aoga mo tagata gasegase o loʻo lipotia le faigata ona pulea amioga faʻafeusuaiga e pei o le matamata tele o ponokalafi i luga ole Initaneti. O se tapulaʻa iloga o le lipoti o le mataupu o loʻo i ai nei, matou te leʻi faʻaaogaina se mamanu (ABA) faʻatasi ma Mr. D. E le gata i lea, o isi suʻega i se faʻataʻitaʻiga lua-tauaso, randomized, placebo-pulea suʻesuʻega iloilo le aoga ma le tolerability o le naltrexone ma ( po'o le leai) psychotherapy mo le togafitia o fa'afitauli o le matamata i ponokalafi ma isi amioga fa'afeusuaiga e mana'omia.

FUAFUAGA

1. Kraus SW, Potenza MN, Martino S, Grant JE. Su'esu'eina o mea tau le mafaufau o le Yale-Brown Obsessive-Compulsive Scale i se fa'ata'ita'iga o tagata fa'aoga tatau ponokalafi. Compr Psychiatry. 2015.

2. Bostwick JM, Bucci JA: O vaisu o feusuaiga i luga ole Initaneti ua togafitia ile naltrexone. i Mayo Clinic Proceedings, Elsevier; 2008. itulau 226-230.

3. Raymond NC, Grant JE, Coleman E. Fa'aopoopoina ma le naltrexone e togafitia ai amioga fa'afeusuaiga fa'amalosi: Se fa'asologa o mataupu. Ann Clin Psychiatry. 2010;22:55-62. 5

 

Numera o Vaiaso Ata 1. Fuafuaga o le Mana'o mo Ponokalafi ma le aofa'i o Aso Va'ai Ponokalafi i Vaiaso Ta'itasi A'o le'i/Po'o le Naltrexone (50mg/d) Mana'o Sikoa (1.0 - Leai se Urge, 7.0 - Intense Urge) Numera o aso na fa'aaogaina ponokalafi i le vaiaso

Naltrexone 50mg/d

faatupeina

O lenei mataupu na lipotia na lagolagoina e le Veterans Affairs Administration, VISN 1 Mental Illness Research Education and Clinical Centers, CASAColumbia ma le National Center for Responsible Gaming. O mea o loʻo i totonu o tusitusiga e atagia ai manatu o tusitala ae le o faʻalapotopotoga faʻatupeina. E le'i iai ni fa'amatalaga a ofisa fa'atupe i mea o lo'o i totonu o tusitusiga.

Faailoaina

Ua lipotia mai e tusitala e leai ni a latou feteenaiga tau tupe e tusa ai ma mea o loʻo i totonu o lenei tusitusiga. Ua maua e Dr. Potenza le lagolago tau tupe po'o se taui mo mea nei: Dr. Potenza sa fa'atalanoa ma fautuaina Lundbeck, Ironwood, Shire, INSYS ma RiverMend Health; ua maua le lagolago su'esu'e (ia Yale) mai le National Institutes of Health, Mohegan Sun Casino, le National Center for Responsible Gaming, ma Pfizer pharmaceuticals; sa auai i su'esu'ega, meli po'o fa'atalanoaga i telefoni e feso'ota'i ma vaisu o fualaau fa'asaina, fa'alavelave fa'atosina po'o isi mataupu tau soifua maloloina; ua feutagai mo taaloga faitupe ma faalapotopotoga faaletulafono i mataupu e faatatau i le pulea o le tuinanau; saunia tausiga fa'afoma'i ile Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; ua faia iloiloga fesoasoani mo le National Institutes of Health ma isi lala sooupu; ua fa'ata'ita'ia po'o fa'asalalauga fa'asalalau fa'apitoa po'o vaega o tala fa'asolopito; na faia lauga fa'alea'oa'oga i ta'amilosaga tetele, fa'alavelave CME ma isi nofoaga fa'apitoa po'o fa'asaienisi; ma ua fa'atupuina tusi po'o mataupu tusi mo le au lomitusi o tusitusiga o le soifua maloloina o le mafaufau.